Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants

Abstract

Excellent adherence and virological suppression are achievable in infants, despite high-frequency NNRTI mutations and rapid disease progression. Infants remain relatively neglected in roll-out programmes and ART provision must be expanded.